Estrogen increases expression of the human prostacyclin receptor within the vasculature through an ERα-dependent mechanism
Files in This Item:
|Turner E2 Reg of PrmIP JMB inc Supp Proofed.pdf||747.2 kB||Adobe PDF||Download|
|Title:||Estrogen increases expression of the human prostacyclin receptor within the vasculature through an ERα-dependent mechanism||Authors:||Turner, Elizebeth C.
Kinsella, B. Therese
|Permanent link:||http://hdl.handle.net/10197/3162||Date:||26-Feb-2010||Online since:||2011-09-21T15:26:35Z||Abstract:||Prostacyclin and the prostacyclin receptor (IP) are implicated in mediating many of the atheroprotective effects of estrogen in both humans and in animal models but through unknown mechanisms. Hence, herein the influence of estrogen on IP gene expression in endothelial EA.hy926, human erythroleukemia 92.1.7 and primary human (h) aortic smooth muscle (1o hAoSM) cells was investigated. Estrogen increased hIP mRNA levels, promoter (PrmIP)-directed reporter gene expression and cicaprost-dependent cAMP generation in all cell types, effects that were abrogated by actinomycinD and the general estrogen receptor (ER)-α/ERβ antagonist ICI 182,780. Furthermore, the ERα-selective agonist 4,4’,4”-(4-Propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT), but not the ERβ-agonist 2,3-bis(4-Hydroxyphenly)-propionitrile, significantly increased hIP mRNA and PrmIP-directed gene expression. Deletional and mutational analysis of PrmIP uncovered an evolutionary conserved estrogen-response element (ERE) while electrophoretic mobility shift, antibody-supershift and chromatin immunoprecipitations assays confirmed the direct binding of ERα, but not ERβ, to PrmIP both in vitro and in vivo. Moreover, immunofluorescence microscopy corroborated that estrogen and PPT increased hIP expression in 1o hAoSMCs. In conclusion, the hIP gene is directly regulated by estrogen that largely occurs through an ERα-dependent transcriptional mechanism and thereby provides critical insights into the role of prostacyclin/hIP in mediating the atheroprotective effects of estrogen within the human vasculature.||Funding Details:||Science Foundation Ireland
Health Research Board
|Type of material:||Journal Article||Publisher:||Elsevier||Journal:||Journal of Molecular Biology||Volume:||396||Issue:||3||Start page:||473||End page:||486||Copyright (published version):||2010 Elsevier Ltd||Keywords:||Prostacyclin receptor; Estrogen; Gene expression; Transcription; Estrogen-response element (ERE); Promoter||Subject LCSH:||Prostacyclin--Receptors
|DOI:||10.1016/j.jmb.2010.01.010||Other versions:||http://dx.doi.org/10.1016/j.jmb.2010.01.010||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Conway Institute Research Collection|
Biomolecular and Biomedical Science Research Collection
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.